Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade. (June 2017)

• Record Type: Journal Article
• Authors: Naidoo, Jarushka; Cappelli, Laura C.; Forde, Patrick M.; Marrone, Kristen A.; Lipson, Evan J.; Hammers, Hans J.; Sharfman, William H.; Le, Dung T.; Baer, Alan N.; Shah, Ami A.; Albayda, Jemima; Manno, Rebecca L.; Haque, Uzma; Gutierrez, Anna Kristina; Bingham, Clifton O.; Brahmer, Julie R.
• Is Part Of: Oncologist. Volume 22:Number 6(2017)
• Page Start: 627
• Page End: 630
• Publication Date: 2017-06
• Subjects: Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1634/theoncologist.2016-0390
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract : This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune‐related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnosis and management of this immune‐related adverse event.